Prof. Dr. ID: 65683

Boris Fehse

graph of relations

Publications

  1. Prognostic effect of calreticulin mutations in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation

    Panagiota, V., Thol, F., Markus, B., Fehse, B., Alchalby, H., Badbaran, A., Lehmann, U., Koenecke, C., Shahswar, R., Chaturvedi, A., Stadler, M., Eder, M., Göhring, G., Koenigsmann, M., Kloos, A., Trummer, A., Schroeder, T., Kobbe, G., Thiede, C., Platzbecker, U., Schlegelberger, B., Kreipe, H-H., Ganser, A., Kröger, N. & Heuser, M., 01.07.2014, In: LEUKEMIA. 28, 7, p. 1552-5 4 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  2. Purging and haemopoietic progenitor cell selection by CD34+ cell separation

    Krüger, W., Gruber, M., Hennings, S., Fehse, N., Fehse, B., Gutensohn, K., Kröger, N. & Zander, A. R., 04.1998, In: BONE MARROW TRANSPL. 21, 7, p. 665-671 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. Purification of CD4+ T cells for adoptive immunotherapy after allogeneic hematopoietic stem cell transplantation

    Klyuchnikov, E., Sputtek, A., Slesarchuk, O., Lioznov, M., Stübig, T., Bacher, U., Amtsfeld, G., Merle, E., Reckhaus, M-L., Fehse, B., Wolschke, C., Adjalle, R., Ayuketang Ayuk, F., Zander, A. R. & Kröger, N., 01.03.2011, In: BIOL BLOOD MARROW TR. 17, 3, p. 374-383 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  4. Quantitative monitoring of NPM1 mutations provides a valid minimal residual disease parameter following allogeneic stem cell transplantation.

    Bacher, U., Badbaran, A., Fehse, B., Zabelina, T., Zander, A. R. & Kröger, N., 2009, In: EXP HEMATOL. 37, 1, p. 135-142 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. Rapid and efficient cloning of proviral flanking fragments by kanamycin resistance gene complementation

    Fehse, B., Kühlcke, K., Langer, A., Ostertag, W. & Lother, H., 15.01.1999, In: NUCLEIC ACIDS RES. 27, 2, p. 706-7 2 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  6. Reduced proliferation of CD34(+) cells from patients with acute myeloid leukemia after gene transfer of INPP5D.

    Metzner, A., Precht, C., Fehse, B., Fiedler, W., Stocking, C., Günther, A., Mayr, G. W. & Jücker, M., 2009, In: GENE THER. 16, 4, p. 570-573 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  7. Remarkable leukemogenic potency and quality of a constitutively active neurotrophin receptor, deltaTrkA.

    Meyer, J., Rhein, M., Schiedlmeier, B., Kustikova, O., Rudolph, C., Kamino, K., Neumann, T., Yang, M., Wahlers, A., Fehse, B., Reuther, G. W., Schlegelberger, B., Ganser, A., Baum, C. & Li, Z., 2007, In: LEUKEMIA. 21, 10, p. 2171-2180 10.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  8. Resistance of mature T cells to oncogene transformation.

    Newrzela, S., Cornils, K., Li, Z., Baum, C., Brugman, M. H., Hartmann, M., Meyer, J., Hartmann, S., Hansmann, M-L., Fehse, B. & von Laer, D., 2008, In: BLOOD. 112, 6, p. 2278-2286 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  9. Retrovirale Vektoren – Effiziente Gentaxis für unterschiedliche Gentherapien

    Morgan, M. A., Galla, M., Fehse, B. & Schambach, A., 30.12.2023, Gen- und Zelltherapie 2.023 - Forschung, klinische Anwendung und Gesellschaft: AG Gentechnologiebericht mit freundlicher Unterstützung der DG-GT und des GSCN. Fehse, B., Schickl, H., Bartfeld, S. & Zenke, M. (eds.). 1 ed. Berlin, Heidelberg: Springer, p. 25-49 25 p.

    Research output: SCORING: Contribution to book/anthologySCORING: Contribution to collected editions/anthologiesTransfer

  10. Retroviral gene therapy in Germany with a view on previous experience and future perspectives

    Morgan, M. A., Galla, M., Grez, M., Fehse, B. & Schambach, A., 09.2021, In: GENE THER. 28, 9, p. 494-512 19 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  11. Retroviral insertional mutagenesis can contribute to immortalization of mature T lymphocytes.

    Newrzela, S., Cornils, K., Heinrich, T., Schläger, J., Yi, J-H., Lysenko, O., Kimpel, J., Fehse, B. & Dorothee, V. L., 2011, In: MOL MED. 17, 11-12, p. 1223-1232 11-12.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  12. Retroviral insertional mutagenesis in telomerase-immortalized hepatocytes identifies RIPK4 as novel tumor suppressor in human hepatocarcinogenesis

    Heim, D., Cornils, K., Schulze, K., Fehse, B., Lohse, A. W., Brümmendorf, T. H. & Wege, H., 2015, In: ONCOGENE. 34, 3, p. 385-393

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  13. Retroviral insertion site analysis in dominant haematopoietic clones.

    Kustikova, O. S., Modlich, U. & Fehse, B., 2009, In: Methods Mol Biol. 506, p. 373-390

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  14. Retroviral integration site analysis in hematopoietic stem cells.

    Kustikova, O. S., Baum, C. & Fehse, B., 2008, In: Methods Mol Biol. 430, p. 255-267

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  15. Retroviral vector insertions in T-lymphocytes used for suicide gene therapy occur in gene groups with specific molecular functions.

    Giordano, F. A., Fehse, B., Hotz-Wagenblatt, A., Jonnakuty, S., Del Val, C., Appelt, J-U., Nagy, K. Z., Kuehlcke, K., Naundorf, S., Zander, A. R., Zeller, W. J., Ho, A. D., Fruehauf, S. & Laufs, S., 2006, In: BONE MARROW TRANSPL. 38, 3, p. 229-235 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  16. Retroviral vector insertion sites associated with dominant hematopoietic clones mark "stemness" pathways.

    Kustikova, O. S., Geiger, H., Li, Z., Brugman, M. H., Chambers, S. M., Shaw, C. A., Pike-Overzet, K., de Ridder, D., Staal, F. J. T., von Keudell, G., Cornils, K., Nattamai, K. J., Modlich, U., Wagemaker, G., Goodell, M. A., Fehse, B. & Baum, C., 2007, In: BLOOD. 109, 5, p. 1897-1907 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  17. Reversal of P-glycoprotein-mediated multidrug resistance by the murine double minute 2 antagonist nutlin-3.

    Michaelis, M., Rothweiler, F., Klassert, D., von Deimling, A., Riecken, K., Fehse, B., Kammerer, B., Doerr, H. W. & Cinatl, J., 2009, In: CANCER RES. 69, 2, p. 416-421 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  18. RGB marking facilitates multicolor clonal cell tracking.

    Riecken, K., Thomaschewski, M., Warlich, M., Volz, T., Cornils, K., Niebuhr, B., Täger, M., Lütgehetmann, M., Pollok, J-M., Stocking, C., Dandri-Petersen, M., Benten, D. & Fehse, B., 2011, In: NAT MED. 17, 4, p. 504-509 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  19. RGB marking : Vielfarbige Zellmarkierung zur klonalen Analyse

    Riecken, K., Thomaschewski, M., Warlich, M., Cornils, K., Benten, D. & Fehse, B., 2012, In: Laborwelt. 13, 1, p. 7-9 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  20. RGB marking with lentiviral vectors for multicolor clonal cell tracking.

    Riecken, K., Thomaschewski, M., Benten, D. & Fehse, B., 2012, In: NAT PHYS. 7, 5, p. 839-849 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  21. Role of Growth arrest-specific gene 6-Mer axis in multiple myeloma

    Waizenegger, J. S., Ben-Batalla, I., Weinhold, N., Meissner, T., Wroblewski, M., Janning, M., Riecken, K., Binder, M., Atanackovic, D., Taipaleenmaeki, H., Schewe, D., Sawall, S., Gensch, V., Cubas-Cordova, M., Seckinger, A., Fiedler, W., Hesse, E., Kröger, N., Fehse, B., Hose, D., Klein, B., Raab, M. S., Pantel, K., Bokemeyer, C. & Loges, S., 01.03.2015, In: LEUKEMIA. 29, 3, p. 696-704 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  22. „Rote Gentechnologie“ – Nachhaltiges Comeback der Gentherapie?!

    Fehse, B., 2018, Vierter Gentechnologiebericht : Bilanzierung einer Hochtechnologie. Hucho, F., Diekämper, J., Fangerau, H., Fehse, B., Hampel, J., Köchy, K., Könninger, S., Marx-Stölting, L., Müller-Röber, B., Reich, J., Schickl, H., Taupitz, J., Walter, J., Zenke, M. & Korte, M. (eds.). 1 ed. Baden-Baden: Nomos Verlagsgesellschaft, p. 210-214 5 p. (Forschungsberichte der Berlin-Brandenburgischen Akademie der Wissenschaften; vol. 40).

    Research output: SCORING: Contribution to book/anthologySCORING: Contribution to collected editions/anthologiesTransfer

  23. Screening and monitoring of MPL W515L mutation with real-time PCR in patients with myelofibrosis undergoing allogeneic-SCT.

    Alchalby, H., Badbaran, A., Bock, O., Fehse, B., Bacher, U., Zander, A. R. & Kröger, N., 2010, In: BONE MARROW TRANSPL. 45, 9, p. 1404-1407 9.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  24. Screening of Potential HIV-1 Inhibitors/Replication Blockers Using Secure Lentiviral in Vitro System.

    Prokofjeva, M. M., Spirin, P. V., Yanvarev, D. V., Ivanov, A. V., Novikov, M. S., Stepanov, O. A., Gottikh, M. B., Kochetkov, S. N., Fehse, B., Stocking, C. & Prassolov, V. S., 2012, In: ACTA NATURAE. 3, 4, p. 55-65 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  25. Selectins mediate small cell lung cancer systemic metastasis

    Heidemann, F., Schildt, A., Schmid, K., Bruns, O. T., Riecken, K., Jung, C., Ittrich, H., Wicklein, D., Reimer, R., Fehse, B., Heeren, J., Lüers, G., Schumacher, U. & Heine, M., 01.01.2014, In: PLOS ONE. 9, 4, p. e92327

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  26. Selective immunoaffinity-based enrichment of CD34+ cells transduced with retroviral vectors containing an intracytoplasmatically truncated version of the human low-affinity nerve growth factor receptor (deltaLNGFR) gene

    Fehse, B., Uhde, A., Fehse, N., Eckert, H. G., Clausen, J., Rüger, R., Koch, S., Ostertag, W., Zander, A. R. & Stockschläder, M., 10.10.1997, In: HUM GENE THER. 8, 15, p. 1815-1824 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  27. Self-inactivating retroviral vectors with improved RNA processing

    Kraunus, J., Schaumann, D. H. S., Meyer, J., Modlich, U., Fehse, B., Brandenburg, G., von Laer, D., Klump, H., Schambach, A., Bohne, J. & Baum, C., 11.2004, In: GENE THER. 11, 21, p. 1568-78 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  28. Sensitive balance of suppressing and activating effects of mesenchymal stem cells on T-cell proliferation.

    Fang, L., Lange, C., Engel, M., Zander, A. R. & Fehse, B., 2006, In: TRANSPLANTATION. 82, 10, p. 1370-1373 10.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  29. SHIP1, but not an AML-derived SHIP1 mutant, suppresses myeloid leukemia growth in a xenotransplantation mouse model

    Täger, M., Horn, S., Latuske, E., Ehm, P., Schaks, M., Nalaskowski, M., Fehse, B., Fiedler, W., Stocking, C., Wellbrock, J. & Jücker, M., 11.2017, In: GENE THER. 24, 11, p. 749-753 5 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  30. Side effects of retroviral gene transfer into hematopoietic stem cells

    Baum, C., Düllmann, J., Li, Z., Fehse, B., Meyer, J., Williams, D. A. & von Kalle, C., 15.03.2003, In: BLOOD. 101, 6, p. 2099-114 16 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  31. Similar outcome of calreticulin type I and calreticulin type II mutations following RIC allogeneic haematopoietic stem cell transplantation for myelofibrosis

    Christopeit, M., Badbaran, A., Zabelina, T., Zeck, G., Fehse, B., Ayuketang, F. A., Wolschke, C. & Kröger, N-M., 10.2016, In: BONE MARROW TRANSPL. 51, 10, p. 1391-1393 3 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  32. Simplified generation of high-titer retrovirus producer cells for clinically relevant retroviral vectors by reversible inclusion of a lox-P-flanked marker gene

    Loew, R., Selevsek, N., Fehse, B., von Laer, D., Baum, C., Fauser, A. & Kuehlcke, K., 05.2004, In: MOL THER. 9, 5, p. 738-46 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  33. SLAMF receptors negatively regulate B cell receptor signaling in chronic lymphocytic leukemia via recruitment of prohibitin-2

    von Wenserski, L., Schultheiß, C., Bolz, S., Schliffke, S., Simnica, D., Willscher, E., Gerull, H., Wolters-Eisfeld, G., Riecken, K., Fehse, B., Altfeld, M., Nollau, P. & Binder, M., 04.2021, In: LEUKEMIA. 35, 4, p. 1073-1086 14 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  34. SOCS3 promotes interleukin-17 expression of human T cells.

    Kleinsteuber, K., Heesch, K., Schattling, S., Sander-Juelch, C., Mock, U., Riecken, K., Fehse, B., Fleischer, B. & Jacobsen, M., 2012, In: BLOOD. 120, 22, p. 4374-4382 22.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  35. Spleen volume and length determined by computed tomography impact outcome after allogeneic stem cell transplantation for myelofibrosis

    Luther, M., Henes, F. O., Zabelina, T., Massoud, R., Janson, D., Wolschke, C., Klyuchnikov, E., Gagelmann, N., Fehse, B., Adam, G., Kröger, N. & Ayuk, F., 07.2023, In: BONE MARROW TRANSPL. 58, 7, p. 755-761 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  36. Stand wissenschaftlicher und medizinischer Entwicklungen

    Fehse, B., Baum, C., Schmidt, M. & Kalle, C., 2011, Gentherapie in Deutschland: Eine interdisziplinäre Bestandsaufnahme. Themenband des Gentechnologieberichts. Forum W - Wissenschaftlicher Verlag, p. 41-126 86 p.

    Research output: SCORING: Contribution to book/anthologySCORING: Contribution to collected editions/anthologiesResearchpeer-review

  37. Stem cell clonality and genotoxicity in hematopoietic cells: gene activation side effects should be avoidable

    von Kalle, C., Fehse, B., Layh-Schmitt, G., Schmidt, M., Kelly, P. & Baum, C., 10.2004, In: SEMIN HEMATOL. 41, 4, p. 303-18 16 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  38. Stem cell clonality -- theoretical concepts, experimental techniques, and clinical challenges

    Glauche, I., Bystrykh, L., Eaves, C., Roeder, I. & other participants, 01.04.2013, In: BLOOD CELL MOL DIS. 50, 4, p. 232-40 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  39. Stem cell marking with promotor-deprived self-inactivating retroviral vectors does not lead to induced clonal imbalance.

    Cornils, K., Lange, C., Schambach, A., Brugman, M. H., Nowak, R., Lioznov, M., Baum, C. & Fehse, B., 2009, In: MOL THER. 17, 1, p. 131-143 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  40. Suicide gene therapy for the treatment of high-grade glioma: past lessons, present trends, and future prospects

    Hossain, J. A., Marchini, A., Fehse, B., Bjerkvig, R. & Miletic, H., 10.07.2020, In: NEURO-ONCOL ADV. 2, 1, p. vdaa013

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  41. Syngenic graft-versus-chronic-myeloid-leukemia-effect?

    Ocheni, S., Schafhausen, P., Bacher, U., Fehse, B. & Kröger, N., 2009, In: CTT-Cell Ther Transpl. 1, 3, p. 66-68 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  42. TALEN-mediated editing of endogenous T-cell receptors facilitates efficient reprogramming of T lymphocytes by lentiviral gene transfer

    Berdien, B., Mock, U., Atanackovic, D. & Fehse, B., 27.03.2014, In: GENE THER. 21, p. 539–548

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  43. Targeting CD38-Expressing Multiple Myeloma and Burkitt Lymphoma Cells In Vitro with Nanobody-Based Chimeric Antigen Receptors (Nb-CARs)

    Hambach, J., Riecken, K., Cichutek, S., Schütze, K., Albrecht, B., Petry, K., Röckendorf, J. L., Baum, N., Kröger, N., Hansen, T., Schuch, G., Haag, F., Adam, G., Fehse, B., Bannas, P. & Koch-Nolte, F., 29.01.2020, In: CELLS-BASEL. 9, 2

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  44. Targeting species D adenoviruses replication to counteract the epidemic keratoconjunctivitis

    Nikitenko, N. A., Speiseder, T., Groitl, P., Spirin, P. V., Prokofjeva, M. M., Lebedev, T. D., Rubtsov, P. M., Lam, E., Riecken, K., Fehse, B., Dobner, T. & Prassolov, V. S., 19.03.2015, In: BIOCHIMIE. 113, p. 10-16

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  45. Temporal dynamics of hippocampal neurogenesis in chronic neurodegeneration

    Gomez-Nicola, D., Suzzi, S., Vargas-Caballero, M., Fransen, N. L., Al-Malki, H., Cebrian-Silla, A., Garcia-Verdugo, J. M., Riecken, K., Fehse, B. & Perry, V. H., 01.08.2014, In: BRAIN. 137, Pt 8, p. 2312-28 17 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  46. The Histogenetic Origin of Malignant Cells Predicts Their Susceptibility towards Synthetic Lethality Utilizing the TK.007 System

    Pallasch, F. B., Freytag, V., Kriegs, M., Gatzemeier, D., Mair, T., Voss, H., Riecken, K., Dawood, M., Fehse, B., Efferth, T., Schlüter, H. & Schumacher, U., 19.06.2024, In: CANCERS. 16, 12, 2278.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  47. The inositol 5-phosphatase SHIP is expressed as 145 and 135 kDa proteins in blood and bone marrow cells in vivo, whereas carboxyl-truncated forms of SHIP are generated by proteolytic cleavage in vitro

    Horn, S., Meyer, J., Heukeshoven, J., Fehse, B., Schulze, C., Li, S., Frey, J., Poll, S., Stocking, C. & Jücker, M., 01.2001, In: LEUKEMIA. 15, 1, p. 112-20 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  48. Themenbereich somatische Gentherapie: aus dem Labor über klinische Studien zum kommerziellen Einsatz

    Fehse, B., 2021, Fünfter Gentechnologiebericht: Sachstand und Perspektiven für Forschung und Anwendung. Fehse, B., Hucho, F., Bartfeld, S., Clemens, S., Erb, T., Fangerau, H., Hampel, J., Korte, M., Marx-Stölting, L., Mundlos, S., Osterheider, A., Pichl, A., Reich, J., Schickl, H., Schicktanz, S., Taupitz, J., Walter, J., Winkler, E. & Zenke, M. (eds.). 1 ed. Baden-Baden: Nomos Verlagsgesellschaft, p. 156-183 28 p. (Forschungsberichte der interdisziplinären Arbeitsgruppen der Berlin-Brandenburgischen Akademie der Wissenschaften).

    Research output: SCORING: Contribution to book/anthologySCORING: Contribution to collected editions/anthologiesTransfer

  49. Themenbereich somatische Gentherapie: Translationale und klinische Forschung

    Fehse, B. & Domasch, S., 2015, Dritter Gentechnologiebericht: Analyse einer Hochtechnologie. Müller-Röber, B., Budisa, N., Diekämper, J., Domasch, S., Fehse, B., Hampel, J., Hucho, F., Hümpel, A., Köchy, K., Marx-Stölting, L., Reich, J., Rheinberger, H-J., Ropers, H-H., Taupitz, J., Walter, J. & Zenke, M. (eds.). 1 ed. Baden Baden: Nomos, p. 211-308 98 p. (Forschungsberichte der Interdisziplinären Arbeitsgruppen der Berlin-Brandenburgischen Akademie der Wissenschaften; vol. 32).

    Research output: SCORING: Contribution to book/anthologySCORING: Contribution to collected editions/anthologiesTransfer

  50. The phosphotyrosine phosphatase SHP2 promotes anergy in chronic lymphocytic leukemia

    Schliffke, S., Buhs, S., Bolz, S., Gerull, H., von Wenserski, L., Riecken, K., Fehse, B., Nollau, P. & Binder, M., 12.04.2018, In: BLOOD. 131, 15, p. 1755-1758 4 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review